Handbook of Disease Burdens and Quality of Life Measures pp 4334-4334 | Cite as
Reference work entry
An oral imidazotetrazinone methylating agent that has demonstrated schedule-dependent activity in several cancers, including gliomas.
KeywordsPublic Health Social Policy
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
© Springer Science+Business Media LLC 2010